XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Fair Value Measurements | 9 Months Ended
--- | ---
Dec. 31, 2023
Fair Value Measurements [Abstract] |
Fair Value Measurements | 14. Fair Value Measurements The following summarizes financial assets and liabilities measured at fair value, by level within the fair value hierarchy:
|  | December 31, 2023 |  |  | March 31, 2023 |
|  |  |  |  | Fair Value Measurements |  |  |  |  |  | Fair Value Measurements |
|  |  |  |  | Using Inputs Considered as |  |  |  |  |  | Using Inputs Considered as |
|  | Fair Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Fair Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-term investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds |  | $ | 2,206,000 |  |  | $ | 2,206,000 |  |  | $ | - |  |  | $ | - |  |  | $ | 2,011,000 |  |  | $ | 2,011,000 |  |  | $ | - |  |  | $ | - |
Prepaid expenses and other current assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forward foreign currency exchange contracts |  |  | 2,118,000 |  |  |  | - |  |  |  | 2,118,000 |  |  |  | - |  |  |  | 3,889,000 |  |  |  | - |  |  |  | 3,889,000 |  |  |  | - |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation |  |  | 2,206,000 |  |  |  | 2,206,000 |  |  |  | - |  |  |  | - |  |  |  | 2,011,000 |  |  |  | 2,011,000 |  |  |  | - |  |  |  | - |
Convertible notes, related party |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compound Net Derivative Liability |  |  | 10,120,000 |  |  |  | - |  |  |  | - |  |  |  | 10,120,000 |  |  |  | 8,430,000 |  |  |  | - |  |  |  | - |  |  |  | 8,430,000 |
Short-term Investments and Deferred Compensation The Company’s short-term investments, which fund its deferred compensation liabilities, consist of investments in mutual funds. These investments are classified as Level 1 as the shares of these mutual funds trade with sufficient frequency and volume to enable the Company to obtain pricing information on an ongoing basis. Forward Foreign Currency Exchange Contracts The forward foreign currency exchange contracts are primarily measured based on the foreign currency spot and forward rates quoted by the banks or foreign currency dealers (See Note 13). Compound Net Derivative Liability The Company estimates the fair value of the Compound Net Derivative Liability (see Note 7) using Level 3 inputs and the Monte Carlo simulation model at the balance sheet date. The Monte Carlo simulation model requires the input of subjective assumptions including the expected volatility of the underlying stock. These subjective assumptions are based on both historical and other information. Changes in the values assumed and used in the model can materially affect the estimate of fair value. This amount is recorded within convertible notes, related party in the condensed consolidated balance sheets at December 31, 2023 and March 31, 2023. Any changes in the fair value of the Compound Net Derivative Liability are recorded in change in fair value of compound net derivative liability in the condensed consolidated statements of operations. The following assumptions were used to determine the fair value of the Compound Net Derivative Liability:
|  | December 31, 2023 |  |  | March 31, 2023 |
Risk free interest rate |  |  | 4.02 | % |  |  | 3.64 | %
Cost of equity |  |  | 23.10 | % |  |  | 21.80 | %
Weighted average cost of capital |  |  | 15.50 | % |  |  | 14.60 | %
Expected volatility of MPA common stock |  |  | 50.00 | % |  |  | 50.00 | %
EBITDA volatility |  |  | 40.00 | % |  |  | 35.00 | %
The following summarizes the activity for Level 3 fair value measurements:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | December 31, |  |  | December 31, |
|  | 2023 |  |  | 2023 |
Beginning balance |  | $ | 8,960,000 |  |  | $ | 8,430,000 |
Changes in fair value of Compound Net Derivative Liability included in earnings |  |  | 1,160,000 |  |  |  | 1,690,000 |
Ending balance |  | $ | 10,120,000 |  |  | $ | 10,120,000 |
During the three and nine months ended December 31, 2023, the Company had no significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition. The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the short-term nature of these instruments. The carrying amounts of the revolving loan and other long-term liabilities approximate their fair value based on the variable nature of interest rates and current rates for instruments with similar characteristics. At December 31, 2023 and March 31, 2023, the net carrying amount of the Convertible Notes was $33,226,000 and $30,994,000, respectively, with unamortized debt discounts and debt issuance costs of $8,894,000 and $9,436,000, respectively, and Compound Net Derivative Liability of $10,120,000 and $8,430,000, respectively. The estimated fair value of the Company’s Convertible Notes was $39,226,000 using Level 3 inputs at December 31, 2023. The net carrying amount of the Convertible Notes approximated their fair value at March 31, 2023, as they were issued on March 31, 2023.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration